Doorgaan naar hoofdcontent

Human medicines European public assessment report (EPAR): Pazenir, paclitaxel, Breast Neoplasms, Date of authorisatio...

 

 
 
Human medicines European public assessment report (EPAR): Pazenir, paclitaxel, Breast Neoplasms, Date of authorisation: 06/05/2019, Revision: 6, Status: Authorised
Human medicines European public assessment report (EPAR): Pazenir, paclitaxel, Breast Neoplasms, Date of authorisation: 06/05/2019, Revision: 6, Status: Authorised



 
 
Human medicines European public assessment report (EPAR): Pelgraz, pegfilgrastim, Neutropenia, Date of authorisation: 21/09/2018, Revision: 6, Status: Authorised
Human medicines European public assessment report (EPAR): Pelgraz, pegfilgrastim, Neutropenia, Date of authorisation: 21/09/2018, Revision: 6, Status: Authorised



 
 
Human medicines European public assessment report (EPAR): Temozolomide Sun, temozolomide, Glioma,Glioblastoma, Date of authorisation: 13/07/2011, Revision: 17, Status: Authorised
Human medicines European public assessment report (EPAR): Temozolomide Sun, temozolomide, Glioma,Glioblastoma, Date of authorisation: 13/07/2011, Revision: 17, Status: Authorised


Actueel zorgnieuws in jouw mailbox ontvangen?
Direct het hele artikel lezen? Meld je aan voor de nieuwsbrief.